ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: INFO08

Informing the Nation About Kidney Disease: The Centers for Disease Control and Prevention's (CDC) Chronic Kidney Disease (CKD) Surveillance System

Session Information

  • Informational Posters
    November 04, 2021 | Location: On-Demand, Virtual Only
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • No subcategory defined

Authors

  • Powe, Neil R., University of California San Francisco, San Francisco, California, United States
  • Burrows, Nilka Rios, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
  • Saran, Rajiv, University of Michigan Division of Nephrology, Ann Arbor, Michigan, United States

Group or Team Name

  • CDC CKD Surveillance Team
Description


Introduction
CKD affects 15% (37 million) of the US adult population and is a growing health burden. The CDC hosts a CKD Surveillance System with aims to raise awareness about CKD, stimulate public health interest and action, and assure progress towards achieving Healthy People 2030 CKD goals.

Methods
The CKD Surveillance System (www.cdc.gov/ckd/surveillance) curates data from 20 different sources to monitor trends and disparities among 299 indicators across six topic areas: CKD incidence/prevalence, awareness, risk factors, health consequences, quality of care delivery, and health system capacity. The system broadened its efforts by updating current data sources, adding new indicators on hypertension and the dietary approaches to stop hypertension (DASH diet), and adding new data sources such as the Department of Defense’s Military Health System.

Results
New indicators show less than 50% awareness of CKD among individuals with the highest 5-year risk of kidney failure. Data show alarmingly low underutilization of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers among individuals with hypertension and severely increased albuminuria, representing a gap in quality of care affecting approximately 1.6 million adults. Bimonthly “Are You Aware” emails were disseminated on surveillance data showing prevalence of current smoking among adults with early-stage CKD, sleep problems being more common in adults with than without CKD, and food insecurity impacting one-quarter of US adults with advanced CKD. These messages reached approximately 36,000 individuals. Website usability was improved with a new navigational function to download charts and with new state and county level visualization. CKD and kidney failure risk calculators and a Disparities Explorer tool increase user interaction with the website. Monthly website traffic in the past year has averaged 4,205 visits. The most frequent uses of the website are for research projects (50%), patient care or patient education (19%), and teaching or presentations (14%).

Conclusion
The CDC CKD Surveillance System has grown and continues to evolve as a resource for the kidney disease community. We seek input on how to improve its usefulness for education, quality improvement, research, health planning, and policy.

Funding

  • Centers for Disease Control and Prevention-Surveillance System for Chronic Kidney Disease